Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue.
about
PARP expression in germ cell tumoursLong-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours.Germ cell tumor clinical trials in North America.Treatment of recurrent germ cell tumors.High dose chemotherapy--results of American studies.High-dose chemotherapy and autologous stem cell transplantation for breast cancer.Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.High-dose chemotherapy in adult patients with germ cell tumors.High-dose chemotherapy and stem cell transplantation for advanced testicular cancerGranulocyte-macrophage colony-stimulating factor (GM-CSF): what role in bone marrow transplantation?High-dose chemotherapy for male germ cell tumor.Management of metastatic germ cell tumors.Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer.A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.18F FDG positron-emission tomography findings of gliomatosis peritonei: A case report and review of the literature.High-dose therapy with stem cell support in solid tumors.A phase II trial of paclitaxel in refractory germ cell tumors.Salvage chemotherapy for metastatic germ cell tumours: The known unknownsHigh-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursSalvage therapy of germ cell tumours.High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer.High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer.Chemotherapy of metastatic testicular germ cell tumors: relationship of histologic response to size reduction and changes in tumor markers.High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours.The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour.High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy.
P2860
Q28287131-4EDA2DA7-FC35-4885-9202-ECBFE08E9CA0Q33383428-71527470-60E9-4DAA-B7A9-7009EB8F0826Q33788909-3D963F63-286B-4653-B3C7-015316301AA5Q33788919-9A766823-3D7D-49A2-AA12-40EE4C6F285AQ33793890-66C2E4B8-D67B-426C-ADCE-D0EEADC08EB5Q33931132-CE6EC255-8780-46F2-BC26-6D374713F14BQ34298244-74D4B4D5-1F47-4168-93BD-7C14CDA7C6F7Q35071101-5648B995-536E-41F1-BE5F-31DE762083E0Q35660641-0E80E173-A28E-4B55-A1E6-26D990B605D9Q35665075-872AB481-6F2E-467F-94A9-7CA705654CA6Q36563573-0754BA50-AAC7-4297-A6C7-C18B7B64FDE6Q37159527-36E69222-78B6-4C81-9926-8C9A9A598309Q37634614-FE6A85E3-CE41-4192-8B78-44C77AA00944Q37875412-7AB93ED3-9E12-4711-8740-976B335C9AC0Q39230788-0BA8D0B1-1AF7-4143-8592-C15F1604DAF9Q40589101-1701B50D-E74E-454A-AE4F-208022EA78FDQ40640064-27C7A42F-E4E0-42E3-A10B-7825FCE47774Q41780611-0529ECD9-6DE5-4FF5-A304-DEA23773F12CQ41925418-A29B3887-1750-40D2-8EBE-A8A375E07AB2Q42280644-BA287BE1-97ED-4A7B-BA69-C853D0A279FDQ42590636-E80BC885-F2D8-4975-8936-6B65C17716F6Q42858699-D641D2B6-47EF-4BF4-953B-467A552E50DAQ43731623-F4955A56-DC5E-42AC-A731-144712DB65B1Q43993231-35038B3D-7A46-409D-AB88-F09F079699D2Q47292232-5CB6C798-D992-4037-B75D-22D9ECA81C04Q53590181-18B7C9CD-1E32-4AC5-B787-3687EA831C11Q53878179-CE7E6E76-09A2-4E07-82E2-6871F4A547BDQ54180890-5EE64C38-6370-4F9F-B725-06F2DDC7DB53Q54205564-95C23166-0BB7-4F43-B9A2-223F81114B24
P2860
Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Long-term outcome of patients ...... autologous bone marrow rescue.
@ast
Long-term outcome of patients ...... autologous bone marrow rescue.
@en
type
label
Long-term outcome of patients ...... autologous bone marrow rescue.
@ast
Long-term outcome of patients ...... autologous bone marrow rescue.
@en
prefLabel
Long-term outcome of patients ...... autologous bone marrow rescue.
@ast
Long-term outcome of patients ...... autologous bone marrow rescue.
@en
P2093
P1476
Long-term outcome of patients ...... autologous bone marrow rescue.
@en
P2093
Einhorn LH
Kneebone P
Loehrer PJ
Nichols CR
Williams SD
P304
P356
10.7326/0003-4819-117-2-124
P407
P577
1992-07-01T00:00:00Z